中国实用外科杂志

• 专题笔谈 • 上一篇    下一篇

胃肠间质瘤新辅助治疗意义与适应证

于吉人杨伟历   

  1. 浙江大学医学院附属第一医院胃肠外科,浙江杭州310003
  • 出版日期:2015-04-01 发布日期:2015-03-31

  • Online:2015-04-01 Published:2015-03-31

摘要:

新辅助治疗是胃肠间质瘤(GIST)的研究热点,其定义、适应证、意义等方面仍须进一步明确。新辅助治疗专指原发性、可切除GIST的术前治疗,适应证包括:术前估计难以达到R0切除;肿瘤体积巨大(直径>10 cm),术中易出血、破裂,可能造成医源性播散;特殊部位的肿瘤,手术易损伤重要脏器功能;肿瘤虽可切除,但估计手术风险较大,术后复发率、病死率较高;预计需要进行多脏器联合切除者。

关键词: 胃肠间质瘤, 新辅助治疗

Abstract:

Significance and indications of neoadjuvant therapy in gastrointestinal stromal tumor        YU Ji-ren, YANG Wei-li. Department of Gastrointestinal Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
Corresponding author: YU Ji-ren, E-mail:yujr0909@zju.edu.cn
Abstract  Neoadjuvant therapy is a research focus in gastrointestinal stromal tumor (GIST). But some aspects such as its definition, indications and significance still need to be clarified further. Neoadjuvant therapy is especially for primary, resectable GIST. The indications include as following: tumor difficult to achieve R0 resection in the preoperative estimation; large tumor (diameter>10cm) lead to bleed, rupture and cause iatrogenic intraperitoneal spread easily; tumor located in the special location and surgery is easy to damage the function of important organ; tumor can be removed with high operation risk, high postoperative recurrence rate and high mortality; tumor combined multiple organs resection is needed possibly in order to achieve R0 resection.

Key words: gastrointestinal stromal tumor, neoadjuvant therapy